Eiger BioPharmaceuticals Inc. (EIGR) Rose 5.87% or 0.82 To Price $14.8 On Monday


Eiger BioPharmaceuticals Inc. (EIGR) rose 5.87% or 0.82 to $14.8. It is near 98480 shares traded, which is 140.03% compare to the average total volume 70330. The market cap of EIGR is $285.05 million. The year to date change is 41.46%. The 52 week price range is from $8.2 to $18.0. Price of EIGR have changed 3.56% during last week. It have changed 5.91% over last month, 37.60% over last 3 months, 15.54% over last 6 months and 38.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 13.65. It is -7.77% below current price. The 200-day Moving Averages for EIGR is 12.01. It is -18.85% below current price. The 52-week High is 18.0. It is 21.62% from the current price. The 52-week Low is 8.2. It is -44.59% from current price.

There are some statistics of EIGR. It is has market cap $285.05 million. The share outstanding is 19.26 million. The average volume is 70330. The percent of top 15 Institution holding is 90.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -118.87%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -73.02%.


Tags:

Share this post